Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Clin Cancer Res. 2016 May 3;22(19):4890–4900. doi: 10.1158/1078-0432.CCR-15-2823

Table 1.

Demographic Data for Patients Included in GWAS (n=616).

Age Median (years) 68.9
Range (years) 41.7-93.5
Body mass index Median (kg/m2) 29.0
Range (kg/m2) 16.1-53.3
Diabetes Yes 97 (15.8%)
No 519 (84.3%)
Treatment arm Bevacizumab 314 (51.0%)
Placebo 302 (49.0%)
Cumulative docetaxel dose Median (mg/m2) 626
Range (mg/m2) 72-2,942
ECOG performance status 0 340 (55.2%)
1 258 (41.9%)
2 18 (2.9%)
Disease type Measurable disease 310 (50.3%)